Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Apax Global Alpha Ltd on Tuesday said that an affiliate of the Apax IX fund will sell its controlling interest in Healthium MedTech Ltd.
Apax Global Alpha is a London-based investment trust. It is a limited partner of the Apax IX fund.
AGA said that the deal values its look-through investment in Healthium at around €22.7 million, a 23% increase to the last unaffected valuation and an uplift of €4.3 million in the adjusted net asset value of AGA at March 31.
Healthium is a Bangalore, India-based medical devices company.
Shares in Apax Global Alpha were down 0.6% at 148.80 pence per share on Tuesday morning.
Copyright 2024 Alliance News Ltd. All Rights Reserved.